In This Section

Nancy Zahniser Memorial Symposium: The Dopamine Transporter in Health and Disease

Sunday April 22, 2018

9:30 am - 12:00 pm Eastern Time (ET)

Room 16B


Chair :

Habibeh Khoshbouei
University of Florida

Lynette Daws
University of Texas Health Science Center at San Antonio

Dr. Zahniser pioneered research elaborating our understanding of how dopamine and glutamate contribute to individual differences in cocaine-induced brain plasticity and addiction-like behavior, and how dopamine transporters are rapidly regulated. Her findings underscore the overall importance of dopamine transporters in contributing to enhanced vulnerability to cocaine addiction and relapse. Dr. Zahniser was strongly committed to mentoring young scientists, and to ASPET. In tribute of her many accomplishments, this symposium captures the most recent advances in understanding dopamine transporter function and regulation, and its important role in health, disease, and addiction. Importantly, this symposium highlights novel targets for treating dopamine-linked pathologies.


Susan Amara - NIMH

Dopamine Transporters and Psychostimulant Action: Lessons from Nancy

Aurelio Galli - University of Alabama-Birmingham

Dopamine Transporters: Linking Obesity to Diabetes to Psychiatric Disorders

Phillip Mackie - University of Florida

Altered Dopamine Transporter Function and Immunoregulation in PD Macrophages

Felix Mayer - Institute of Pharmacology, Medical University of Vienna

An Unsuspected Role for Organic Cation Transporter 3 in the Actions of Amphetamine

Lynette Daws - University of Texas Health Science Center at San Antonio

DATS Not All: Organic Cation Transporters in the Actions of Psychoactive Drugs

Margaret Gnegy - University of Michigan

Modulation of Stimulant Actions by the Intertwining Activities of D2 Autoreceptors and PKCbeta

Ulrik Gether - University of Copenhagen

Moving from Neuronal Transporter Structures to Clinically Relevant Therapeutics for Neurodegenerative Disorders